Literature DB >> 23452696

A comparison of warming interventions on the temperatures of inpatients undergoing colorectal surgery.

Martha Nicholson1.   

Abstract

This study compared the effects of two different warming interventions in the preoperative setting on the preoperative, intraoperative, and postoperative temperatures of patients undergoing colorectal surgery in an inpatient setting. The study was performed to determine whether prewarming patients for at least 30 minutes would result in postoperative temperatures of 36° C (96.8° F) or higher within 15 minutes of their arrival in the postanesthesia care unit. The results indicated that prewarming devices did not result in reduced proportions of patients who subsequently experienced hypothermia. One reason may be that all the patients were warmed with a forced-air warming device before induction in the OR. Our study does not recommend a specific intervention for a prewarming strategy but indicates that prewarming may contribute to normothermia in the immediate postoperative period.
Copyright © 2013 AORN, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23452696     DOI: 10.1016/j.aorn.2012.12.018

Source DB:  PubMed          Journal:  AORN J        ISSN: 0001-2092            Impact factor:   0.676


  3 in total

1.  Physiological Factor Evaluation of the Warm Humidification of Anesthetic Gas Nursing Care.

Authors:  Hyosun Park; Nayeon Shin
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Oct-Dec

2.  Effect of preheating on the maintenance of body temperature in surgical patients: a randomized clinical trial.

Authors:  Cibele Cristina Tramontini Fuganti; Edson Zangiacomi Martinez; Cristina Maria Galvão
Journal:  Rev Lat Am Enfermagem       Date:  2018-10-25

3.  Optimal Application of Forced Air Warming to Prevent Peri-Operative Hypothermia during Abdominal Surgery: A Systematic Review and Meta-Analysis.

Authors:  Yoonyoung Lee; Kisook Kim
Journal:  Int J Environ Res Public Health       Date:  2021-03-03       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.